Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography

JACC Cardiovasc Interv. 2009 May;2(5):445-52. doi: 10.1016/j.jcin.2009.01.012.

Abstract

Objectives: The aim of this study was to compare the frequency of incomplete stent apposition (ISA) and struts not covered by tissue at long-term follow-up (as assessed by optical coherence tomography [OCT]) in drug-eluting stents (DES) implanted during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) versus DES implanted for unstable and stable angina.

Background: Incomplete stent apposition and the absence of strut endothelialization might be linked to stent thrombosis. DES implanted for STEMI might have a higher risk of thrombosis.

Methods: Consecutive patients in whom OCT was performed at least 6 months after DES implantation were included in the study. Stent struts were classified on the basis of the presence or absence of ISA and tissue coverage.

Results: Forty-seven lesions in 43 patients (1,356 frames, 10,140 struts) were analyzed (49% stable angina, 17% unstable angina, 34% STEMI). Median follow-up time was 9 (range 7 to 72) months. Drug-eluting stents implanted during primary PCI presented ISA more often than DES implanted in stable/unstable angina patients (75% vs. 25.8%, p = 0.001). The frequency of uncovered struts was also higher in the STEMI group (93.8% vs. 67.7%, p = 0.048). On multivariate analysis, DES implantation in STEMI was the only independent predictor of ISA (odds ratio: 9.8, 95% confidence interval: 2.4 to 40.4, p = 0.002) and the presence of uncovered struts at follow-up (odds ratio: 9.5, 95% confidence interval: 1.0 to 90.3, p = 0.049).

Conclusions: DES implanted for STEMI had a higher frequency of incompletely apposed struts and uncovered struts as assessed by OCT at follow-up. DES implantation during primary PCI in STEMI was an independent predictor of ISA and the presence of uncovered struts at follow-up.

Publication types

  • Comparative Study

MeSH terms

  • Angina Pectoris / drug therapy
  • Angina Pectoris / therapy
  • Angina, Unstable / drug therapy*
  • Angina, Unstable / therapy
  • Angioplasty, Balloon, Coronary*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Coronary Restenosis / prevention & control
  • Drug-Eluting Stents*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / pathology
  • Everolimus
  • Female
  • Humans
  • Immunosuppressive Agents
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / therapy
  • Paclitaxel / therapeutic use
  • Prospective Studies
  • Risk Factors
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use
  • Tomography, Optical Coherence*

Substances

  • Antineoplastic Agents, Phytogenic
  • Immunosuppressive Agents
  • Everolimus
  • Paclitaxel
  • Sirolimus